ALSO NOTED: Pfizer beefs up Chantix suicide warning; Actavis buys Italian Pfizer plant;

> Pfizer strengthened the suicide warning on its stop-smoking drug Chantix as the FDA reviews reports of patients who experienced psychiatric problems while on the drug. Report

> Generics maker Actavis has agreed to buy a Pfizer manufacturing facility that specializes in cancer treatments; the plant is near Milan, Italy, and employs about 340. Release

> The British Medical Association bristled at a government report suggesting that doctors overprescribe brand-name meds, while the pharma industry needled the NHS for being slow to adopt new drugs. Report

> India asked Indonesia to remove trade barriers that inhibit the importation of Indian drugs. Report

> India's Nicholas Piramal boosted its net profit by 31 percent in the third quarter as revenues rose to 7.36 billion rupees, or $188 million. Report

> Scientists in California made embryo clones of two men, a step toward developing new stem cells for therapeutic purposes. Report

> There's been a growing understanding in the drug development world that studies boasting of positive data on a drug tend to get published in the scientific literature with great fanfare; negative studies are often silently allowed to sink out from sight. Report

And Finally... The most aggressive form of skin cancer, Merkel cell carcinoma, may be caused by a previously unknown virus. Report

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.